Doctrine page

Not Worked in the Territory of India

Must a patent be manufactured in India to be worked in the territory of India?

Under section 84(1)(c), read through the prism of section 83, the contention that worked in India must in all cases mean only manufactured in India is not acceptable.

Doctrine last updated on 14 November 2026

Cite this page

Not Worked in the Territory of India, Ali on Patents, www.aop.onl/not-worked-in-india

1The expression ‘patented invention’ is not defined in the Patents Act though it is used in various provisions of the Patents Act. The Patents Act provides for a definition for ‘patented article’. Section 2(1)(o) defines a ‘patented article’ and ‘patented process’ to mean respectively an article or process in respect of which a patent is in force. A patent means a patent for any invention granted under the Patents Act. (Patents Act 1970, s 2(1)(m).) Section 82 extends the scope of ‘patented article’ by including an article made by a patented process, for the purpose of ch XVI of the Patents Act. Thus, a patented invention can be taken to mean an invention in respect of which a patent is in force and includes both ‘patented article’ as well as ‘patented process’. (Ibid, s 2(1)(j) which defines an invention to include both a product and a process. The expression ‘patented article or process’ has been used in ss 84(7)(b), 88(1), 140(2) and 141(1).) In determining whether the article or process is manufactured or carried in the country, it is immaterial to consider whether it was so manufactured or carried in derogation to the rights of the patentee under his patent. The Controller need not get into the question of construction of patent. (See Mercedes Daimler Motor Co Ltd’s Patents (1910) 27 RPC 762, p 768.)

2The expression ‘adequate’ is an ’elastic’ expression which will depend on the facts and circumstances of each case. In Hatschek’s Patent, it was held that the extent of manufacture of an article cannot be regarded as adequate if it is less than what it would have been but for the fact that the patentee has exercised the rights conferred by his patent to the hurt of the national industry, ie, by giving preference to foreign traders over national traders. (Hatschek’s Patent [1909] 2 Ch 68, p 85, (1909) 26 RPC 228.) In determining the extent of adequacy, Parker J said: (Ibid, p 86.)

Similarly I do not think that any reasons can be satisfactory which do not account for the inadequacy of the extent to which the patented article is manufactured or the patented process is carried on in this country by causes operating irrespective of any abuse of the monopoly granted by the patent. The first thing, therefore, for the patentee to do is, by full disclosure of the manner in which he has exercised his patent rights, to free himself from all suspicion of having done anything to hamper the industry of the United Kingdom. When once he has satisfied the Comptroller of this he will have gone a long way towards proving what he has to prove, and, even if he cannot prove adequacy, ought to be able to shew satisfactory reasons for inadequacy…It is therefore the conduct of the patentee which is in question. Has he done anything which he ought not to have done, or omitted to do anything which he ought to have done, having regard to his obligations towards the traders of this country?’

3Parker J continued: (Ibid, pp 88-89.)

Certainly the fact that persons carrying on the industry in this country would make smaller profits than persons carrying it on abroad would, in my opinion, be no satisfactory reason at all. I can conceive cases in which a patentee, having obtained a patent, may find it impossible to work it in the United Kingdom because of the nature of the invention, or because of local conditions which prevail here, but not in other countries, although these cases must, I think, be rare, and may be exceedingly difficult to prove. The extra cost of labour or material may well be counterbalanced by superior skill or in other ways. But it can never, in my opinion, be sufficient for a patentee defending himself under the section to prove that he cannot now start an industry with any chance of profit.

4But there may be genuine cases where the patentee cannot start an industry expecting any profit. The patentee may present a defence that establishing an industry would have been unprofitable or that it would have lead to a loss. (See Boult’s Patent (1909) 26 RPC 383; Kent’s Patent (1909) 26 RPC 666, p 670.) In fact, the Patents Act permits revision of the terms of the licence on the ground that the licensee is unable to work the invention except at a loss. (Patents Act 1970, s 88(4).) There is no reason why the patentee cannot take the plea of working of the invention leading to a loss as a defence.

5The fact that working the invention required people with special skills who could only be found abroad will not be an excuse for not working the invention within the country. (See Johnson’s Patent (1909) 26 RPC 52. It was contended in this case that owing to special tools and to the precision required in making patented machines certain important parts could not be made in United Kingdom or could only be so made with great difficulty and expense and after a long time. It was also submitted that serious practical obstacles in the way of its working. See also Wardwell’s Patent (1913) 30 RPC 408; Hamson (A) & Sons (London) Ltd’s Application (1958) RPC 88.) However, it should be acceptable if more time is taken for working the invention as the patentee who desires to put the best possible machine upon the market can be expected ’to be somewhat over-scrupulous at first in obtaining his materials, and supervising the construction of his machine’. (Kent’s Patent (1909) 26 RPC 666, p 670.)

6There could also be instances where the working of a patented invention within India on a commercial scale is prevented by the importation of the patented article from abroad by the patentee or by persons purchasing from the patentee or by persons against whom the patentee has not taken any action for infringement. In the above circumstances, it will be deemed that the reasonable requirements have not been met. But importation need not necessarily prevent the working of a patented article in a country it may also create a demand for the imported article. A market for a patented invention cannot be created solely on importation. (See Fette’s Patent (1961) RPC 396.)

7The requirement of working the patented invention within the country on a commercial scale had caused some difficulty in ascertaining whether a patented invention has actually been worked if it is merely formulated in the country after being imported from abroad. In the context of the UK Patents Act 1977, it was observed by Falconer J in Smith Kline & French Laboratories Ltd’s (Cimetidine) Patents: ((1990) RPC 203, pp 224-25 (CA). The judgment of the Patents Court given by Falconer J was reproduced in the decision of the Court of Appeal.)

It seems to me that the mere formulation in the United Kingdom of cimetidine manufactured in Ireland and imported therefrom does not, as a matter of substance, amount to a commercial working of the patented invention of each of the patents to the fullest extent reasonably practicable in the United Kingdom. The patents contain product and process claims and it seems to me that, even for the formulation claim in each patent, commercial working in the United Kingdom to the fullest extent reasonably practicable of the invention so claimed is not obtained with manufacture of the basic active ingredient in a foreign country. It has not been suggested that the raw material cimetidine could not be manufactured in this country. However, I accept, as the superintending examiner concluded, that considering SK&F’s position under section 50(1)(c), as an interest SK&F has a significant investment in the United Kingdom devoted to making up of pharmaceutical formulations of the cimetidine SK&F imports from Ireland and that is a relevant matter to be taken into account.

8A compulsory licence on the patent may be granted if the patented invention is not worked in the territory of India. (Patents Act 1970, s 84(1)(c).) The above ground overlaps with s 84(1)(a) of the Patents Act as the conditions where the reasonable requirement of the public has not been satisfied includes the grounds under s 84(7)(d) and (e). Clauses (d) and (e) of s 84(7) explain the conditions where the patented invention is not worked in India. If the Controller is satisfied that the patentable invention does not satisfy the reasonable requirements of the public or is not worked in India or is not available at an affordable price, the Controller may grant the licence upon the terms that he deems fit. The Controller may also grant a compulsory licence where the working of the patented invention is prevented or hindered by the import of the patented article from abroad. The fact that the patentable invention is not worked in India can be a separate ground in itself, distinct from the reasonable requirement of public, for the grant of a compulsory licence. (Ibid.) The foregoing discussion on ‘patented invention’ in para 22.45 will be relevant for the purpose of the above ground as well.

9There may be many reasons as to why an invention may not be worked by the patentee or its licensee. Where the patentee takes a plea that it did not have enough time to exploit the invention commercially, the Controller shall determine the date of sealing (the date of grant under the Patents Act) of the patent before considering such a plea. (Hamson (A) & Son (London) Ltd’s Application (1958) RPC 88.) If special tools or specially skilled labour have to be imported into a particular country to work a patented invention, it will be regarded that the patented invention is not capable of being worked in that country. (Johnson’s Patent (1909) 26 RPC 52; Wardwell’s Patent (1913) 30 RPC 408.) Inventions which work under a licence in one country but do not work in another can lead to a situation where the patentee should explain the non-working. (Hamson (A) & Son (London) Ltd’s Application (1958) RPC 88, pp 89-90.) In some cases, the working of a patent would be prevented by threat of an infringmeent due to the existence of another patent, as such working may lead to infringment of the other patent. (See Taylor’s Patent [1912] 1 Ch 635, (1912) 29 RPC 296.)

10In Bayer v Union of India (2014) the Division Bench of the Bombay High Court held that “whether the invention is being worked in territory of India has to be looked at through the prism of Section 83 of the Act which contains the legislative guidelines to govern the meaning of the words ‘worked in the territory of India’”, and that “when a patent holder is faced with an application for Compulsory License, it is for the patent holder to show that the patented invention/ drug is worked in the territory of India by manufacture or otherwise. Manufacture in all cases may not be necessary to establish working in India as held by the Tribunal. However, the patent holder would nevertheless have to satisfy the authorities under the Act as to why the patented invention was not being manufactured in India keeping in view Section 83 of the Act.” It held that “the contention of Union of India that ‘worked in India’ must in all cases mean only manufactured in India is not acceptable”, and that reliance upon Article 27 of TRIPS “ignores the exceptions thereto provided in Articles 30 and 31 of TRIPS.” (para 15)

11But in Cipla v Novartis (2017) the Division Bench of the Delhi High Court, dismissing an appeal against an interim injunction, held that “it is not at all necessary that for a patent to be worked in India, the product in question must be manufactured in India”, and that “As pointed out in Telemecanique (supra), a patent can be worked in India even through imports. All that is to be seen is that the imports are of a sufficient quantity so as to meet the demands for the product. This is of particular importance in the case of pharmaceutical products.” On the material before it the Bench said that “we cannot make a definitive conclusion as to whether the extent of imports is not sufficient for meeting the demands of COPD patients in India”, that question being “a matter of evidence which can only be thrashed out in the course of a trial.” (para 25)

Provisions and topics

Provisions
Topics

Cases on this page

Case page

Bayer Corporation v Union of India (2014)

High Court of Bombay·15 July 2014

Case page

Cipla Limited v Novartis AG (2017)

High Court of Delhi·9 March 2017

See also

Doctrine page

Reasonable Requirements of the Public

Does a patentee have to meet the demand for a patented medicine in full?

Doctrine page

Compulsory Licences: The Scheme

Is Chapter XVI a complete code on abuse of patent rights?

Doctrine page

Revocation by the Controller for Non-working

When can the Controller revoke a patent for non-working after a compulsory licence has been granted?

Doctrine page · Written by Prof. Feroz Ali

www.aop.onl/not-worked-in-india